L-Aspartic acid,N-[(2E,4E,6E,8E,10E)-12-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,12-dioxo-2,4,6,8,10-dodecapentaenyl]-(9CI) (220379-13-5)

Identification
Name:	L-Aspartic acid,N-[(2E,4E,6E,8E,10E)-12-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,12-dioxo-2,4,6,8,10-dodecapentaenyl]-(9CI)
Synonyms:	BoletocrocinC
CAS:	220379-13-5
Molecular Formula:	C22H28 N2 O8
Molecular Structure:
Properties
Safety Data

Other Product

L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E)-14-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,14-dioxo-2,4,6,8,10,12-tetradecahexaenyl]-(9CI)
L-Glutamic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S,2S)-1-carboxy-2-methylbutyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
L-Aspartic acid,N-[(2E,4E,6E,8E,10E,12E,14E)-16-[[(1S)-1-carboxy-2-methylpropyl]amino]-1,16-dioxo-2,4,6,8,10,12,14-hexadecaheptaenyl]-(9CI)
1H-Pyrrole-2-propanoicacid,2,5-dihydro-3-hydroxy-1-methyl-5-oxo-4-[(2E,4E,6E,8E,10E)-1-oxo-2,4,6,8,10-dodecapentaenyl]-,(2R)- (9CI)
L-Proline,N-[(2E,4E,6E,8E,10E)-12-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-1,12-dioxo-2,4,6,8,10-dodecapentaen-1-yl]-L-phenylalanyl-L-seryl-L-prolyl-N-methyl-L-alanyl-L-alanyl-4-methyl-,(6®2)-lactone, (4R)-
(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethylnon-3-en-1-yl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl (2E,4E,6E,8E,10E,12S,13S,15S)-12,13,15-trihydroxy-4,6,10-trimethylhexadeca-2,4,6,8,10-pentaenoate
2,4,6,8,10,14-Hexadecahexaenamide,13-hydroxy-N-[(1S)-2-methoxy-1-methylethyl]-2,10,12,14-tetramethyl-,(2E,4E,6E,8E,10E,12R,13R,14E)-
L-Glutamine,N2-[(2E,4E,6E,8E,10E)-11-[2-(acetylamino)-3-hydroxyphenyl]-1-oxo-2,4,6,8,10-undecapentaenyl]-(9CI)
2,4,6,8,10-Hexadecapentaenoic acid,12,13,15-trihydroxy-4,6,10-trimethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,4E,6E,8E,10E,12S,13S,15S)-
2,4,6,8,10-Hexadecapentaenoic acid,12,13,15-trihydroxy-2,4,6,10-tetramethyl-,(6S,7S,9E,12R)-12-[(1S,3E,5R,6R,8R)-6,8-dihydroxy-1,3,5-trimethyl-3-nonenyl]-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl ester,(2E,4E,6E,8E,10E,12S,13S,15S)-
b-D-Galactopyranoside,(1S,3'R,4'R,5'R,6'R)-3',4',5',6'-tetrahydro-3',5,7-trihydroxy-4'-[[(2E,4E,8E,10E)-7-hydroxy-8,14-dimethyl-1-oxo-2,4,8,10-hexadecatetraenyl]oxy]-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-5'-yl,6-[(2E,4Z,6E)-8-hydroxy-2,4,6-decatrienoate] (9CI)
b-D-Glucopyranoside,(1S,4E,8E,12Z)-14-[[O-6-deoxy-2-O-[(2E,4R,6E,10E,14S)-14-(b-D-glucopyranosyloxy)-4-hydroxy-2,6,10,14-tetramethyl-1-oxo-2,6,10,15-hexadecatetraenyl]-a-L-mannopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®3)-6-deoxy-a-L-mannopyranosyl]oxy]-1-ethenyl-1,5,9,13-tetramethyl-4,8,12-tetradecatrienyl2-O-b-D-glucopyranosyl- (9CI)
1-12-Bombesin,12-[N-[(1S,2S)-4-amino-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl]-L-histidinamide]-(9CI)
2,4,6,8,10,14-Octadecahexaenamide,13-hydroxy-N-[(1S)-2-hydroxy-1-methylethyl]-2,10,12,14,16-pentamethyl-18-phenyl-,(2E,4E,6E,8E,10E,12R,13R,14E,16S)-
2,4,8-Tetradecatrienamide,N-[(1S,2R)-2-hydroxy-1-[[[(3E,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-,(2E,4E,8E)- (9CI)
2,4,6,8,10,12,14-Hexadecaheptaenediamide,N,N'-bis(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-, (2E,4E,6E,8E,10E,12E,14E)- (9CI)
2,6,10-Dodecatrienoic acid,6,10-dimethyl-12-(5-methyl-3,6-dioxo- 1,4-cyclohexadien-1-yl)-2-(4-methyl-3- pentenyl)-,(2E,6E,10E)-
2,4,6,8,10,12,14,16-Heptadecaoctaenoicacid,17-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-2,6,11,15-tetramethyl-,(2E,4E,6E,8E,10E,12E,14E,16E)- (9CI)
(2E,4E,6E,8E)-12-hydroxyicosa-2,4,6,8-tetraenoic acid